HCC and Immunotherapy: The Potential Predictive Role of Gut Microbiota and Future Therapeutic Strategies
During the last decade, a new therapeutic revolution has involved the management of hepatocellular carcinoma (HCC). This is made possible thanks to the documented efficacy of immunotherapy for this disease. In addition, new evidence has demonstrated the role of the gut–liver axis and gut microbiota...
Saved in:
| Main Authors: | Carmelo Laface, Eleonora Lauricella, Girolamo Ranieri, Francesca Ambrogio, Felicia Maria Maselli, Elena Parlagreco, Giulia Bernardi, Elena Fea, Gianmauro Numico |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Onco |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-7523/5/1/9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world efficacy of cabozantinib alone or in combination with ICIs in heavily pretreated hepatocellular carcinoma: potential role of AXL and MET expression
by: Kuan-Chang Lai, et al.
Published: (2025-07-01) -
Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapy
by: Pei-Chang Lee, et al.
Published: (2025-09-01) -
Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy
by: Fayuan Wang, et al.
Published: (2025-06-01) -
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies
by: Liu X, et al.
Published: (2025-06-01) -
The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances
by: Maja Pezer Naletilić, et al.
Published: (2025-05-01)